CM Life Sciences, Inc. (NASDAQ: CMLFU) Stock Competitors & Peer Comparison
See CMLFU's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Shell Companies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for CMLFU and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CMLFU | $13.00 | -4.55% | 10.3B | -1444.44 | -$0.01 | N/A |
| CCIV | $24.25 | +5.90% | 44.4B | N/A | N/A | N/A |
| PSACU | $17.08 | +0.35% | 12B | -108.79 | -$0.16 | N/A |
| RTPY | $9.91 | -0.30% | 11.6B | N/A | N/A | N/A |
| LVRAW | $0.04 | +0.00% | 11.5B | N/A | N/A | N/A |
| PSAC | $13.78 | -0.36% | 9.7B | N/A | N/A | N/A |
| GRSVU | $11.39 | +3.36% | 6.8B | N/A | N/A | N/A |
| APSG | $7.39 | -25.88% | 6.3B | 36.95 | $0.20 | N/A |
| RTP | $10.03 | -4.48% | 6.3B | N/A | N/A | N/A |
| DGNR | $9.26 | +1.09% | 5.8B | -308.67 | -$0.03 | N/A |
Stock Comparison
Lucid Group, Inc. (NYSE: CCIV)
CMLFU vs CCIV Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, CCIV has a market cap of 44.4B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while CCIV trades at $24.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas CCIV's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to CCIV's ROE of -13.92%. Regarding short-term risk, CMLFU is less volatile compared to CCIV. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check CCIV's competition here
Property Solutions Acquisition Corp. (NASDAQ: PSACU)
CMLFU vs PSACU Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, PSACU has a market cap of 12B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while PSACU trades at $17.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas PSACU's P/E ratio is -108.79. In terms of profitability, CMLFU's ROE is -0.39%, compared to PSACU's ROE of -35.44%. Regarding short-term risk, CMLFU is less volatile compared to PSACU. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check PSACU's competition here
Reinvent Technology Partners Y (NASDAQ: RTPY)
CMLFU vs RTPY Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, RTPY has a market cap of 11.6B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while RTPY trades at $9.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas RTPY's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to RTPY's ROE of -0.43%. Regarding short-term risk, CMLFU is less volatile compared to RTPY. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check RTPY's competition here
Levere Holdings Corp. (NASDAQ: LVRAW)
CMLFU vs LVRAW Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, LVRAW has a market cap of 11.5B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while LVRAW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas LVRAW's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to LVRAW's ROE of N/A. Regarding short-term risk, CMLFU is less volatile compared to LVRAW. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check LVRAW's competition here
Property Solutions Acquisition Corp. (NASDAQ: PSAC)
CMLFU vs PSAC Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, PSAC has a market cap of 9.7B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while PSAC trades at $13.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas PSAC's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to PSAC's ROE of -35.44%. Regarding short-term risk, CMLFU is less volatile compared to PSAC. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check PSAC's competition here
Gores Holdings V, Inc. (NASDAQ: GRSVU)
CMLFU vs GRSVU Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, GRSVU has a market cap of 6.8B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while GRSVU trades at $11.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas GRSVU's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to GRSVU's ROE of +0.00%. Regarding short-term risk, CMLFU is more volatile compared to GRSVU. This indicates higher risk in terms of short-term price fluctuations for CMLFU.Check GRSVU's competition here
Apollo Strategic Growth Capital (NYSE: APSG)
CMLFU vs APSG Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, APSG has a market cap of 6.3B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while APSG trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas APSG's P/E ratio is 36.95. In terms of profitability, CMLFU's ROE is -0.39%, compared to APSG's ROE of +0.03%. Regarding short-term risk, CMLFU is less volatile compared to APSG. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check APSG's competition here
Reinvent Technology Partners (NYSE: RTP)
CMLFU vs RTP Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, RTP has a market cap of 6.3B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while RTP trades at $10.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas RTP's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to RTP's ROE of -0.58%. Regarding short-term risk, CMLFU is less volatile compared to RTP. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check RTP's competition here
Dragoneer Growth Opportunities Corp. (NYSE: DGNR)
CMLFU vs DGNR Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, DGNR has a market cap of 5.8B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while DGNR trades at $9.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas DGNR's P/E ratio is -308.67. In terms of profitability, CMLFU's ROE is -0.39%, compared to DGNR's ROE of +0.02%. Regarding short-term risk, CMLFU is more volatile compared to DGNR. This indicates higher risk in terms of short-term price fluctuations for CMLFU.Check DGNR's competition here
VectoIQ Acquisition Corp. II (NASDAQ: VTIQ)
CMLFU vs VTIQ Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, VTIQ has a market cap of 5.6B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while VTIQ trades at $10.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas VTIQ's P/E ratio is 91.50. In terms of profitability, CMLFU's ROE is -0.39%, compared to VTIQ's ROE of +472.81%. Regarding short-term risk, CMLFU is more volatile compared to VTIQ. This indicates higher risk in terms of short-term price fluctuations for CMLFU.Check VTIQ's competition here
VectoIQ Acquisition Corp. II (NASDAQ: VTIQU)
CMLFU vs VTIQU Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, VTIQU has a market cap of 5.6B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while VTIQU trades at $10.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas VTIQU's P/E ratio is 100.60. In terms of profitability, CMLFU's ROE is -0.39%, compared to VTIQU's ROE of +472.81%. Regarding short-term risk, CMLFU is more volatile compared to VTIQU. This indicates higher risk in terms of short-term price fluctuations for CMLFU.Check VTIQU's competition here
Vector Acquisition Corporation (NASDAQ: VACQ)
CMLFU vs VACQ Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, VACQ has a market cap of 5.5B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while VACQ trades at $11.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas VACQ's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to VACQ's ROE of -0.12%. Regarding short-term risk, CMLFU is less volatile compared to VACQ. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check VACQ's competition here
SVF Investment Corp. 3 (NASDAQ: SVFC)
CMLFU vs SVFC Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, SVFC has a market cap of 5.1B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while SVFC trades at $9.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas SVFC's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to SVFC's ROE of +0.05%. Regarding short-term risk, CMLFU is less volatile compared to SVFC. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check SVFC's competition here
VG Acquisition Corp. (NYSE: VGAC)
CMLFU vs VGAC Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, VGAC has a market cap of 5B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while VGAC trades at $10.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas VGAC's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to VGAC's ROE of -1.21%. Regarding short-term risk, CMLFU is less volatile compared to VGAC. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check VGAC's competition here
CM Life Sciences III Inc. (NASDAQ: CMLT)
CMLFU vs CMLT Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, CMLT has a market cap of 4.2B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while CMLT trades at $8.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas CMLT's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to CMLT's ROE of N/A. Regarding short-term risk, CMLFU is less volatile compared to CMLT. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check CMLT's competition here
Gores Holdings VI, Inc. (NASDAQ: GHVI)
CMLFU vs GHVI Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, GHVI has a market cap of 4.2B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while GHVI trades at $14.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas GHVI's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to GHVI's ROE of -1.28%. Regarding short-term risk, CMLFU is less volatile compared to GHVI. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check GHVI's competition here
Nextdoor Holdings, Inc. (NASDAQ: KVSB)
CMLFU vs KVSB Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, KVSB has a market cap of 4.2B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while KVSB trades at $11.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas KVSB's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to KVSB's ROE of -0.07%. Regarding short-term risk, CMLFU is less volatile compared to KVSB. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check KVSB's competition here
FTAC Olympus Acquisition Corp. (NASDAQ: FTOCU)
CMLFU vs FTOCU Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, FTOCU has a market cap of 4.1B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while FTOCU trades at $11.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas FTOCU's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to FTOCU's ROE of +0.07%. Regarding short-term risk, CMLFU is more volatile compared to FTOCU. This indicates higher risk in terms of short-term price fluctuations for CMLFU.Check FTOCU's competition here
Tuscan Holdings Corp. (NASDAQ: THCBU)
CMLFU vs THCBU Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, THCBU has a market cap of 3.9B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while THCBU trades at $12.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas THCBU's P/E ratio is -101.87. In terms of profitability, CMLFU's ROE is -0.39%, compared to THCBU's ROE of -0.23%. Regarding short-term risk, CMLFU is less volatile compared to THCBU. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check THCBU's competition here
Climate Change Crisis Real Impact I Acquisition Corporation (NYSE: CLII)
CMLFU vs CLII Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, CLII has a market cap of 3.8B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while CLII trades at $14.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas CLII's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to CLII's ROE of -0.31%. Regarding short-term risk, CMLFU is less volatile compared to CLII. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check CLII's competition here
GreenVision Acquisition Corp. (NASDAQ: GRNV)
CMLFU vs GRNV Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, GRNV has a market cap of 3.8B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while GRNV trades at $12.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas GRNV's P/E ratio is -59.68. In terms of profitability, CMLFU's ROE is -0.39%, compared to GRNV's ROE of +0.05%. Regarding short-term risk, CMLFU is less volatile compared to GRNV. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check GRNV's competition here
Forest Road Acquisition Corp. (NYSE: FRX)
CMLFU vs FRX Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, FRX has a market cap of 3.7B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while FRX trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas FRX's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to FRX's ROE of +0.19%. Regarding short-term risk, CMLFU is less volatile compared to FRX. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check FRX's competition here
Holicity Inc. (NASDAQ: HOLUU)
CMLFU vs HOLUU Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, HOLUU has a market cap of 3.7B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while HOLUU trades at $13.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas HOLUU's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to HOLUU's ROE of -0.13%. Regarding short-term risk, CMLFU is less volatile compared to HOLUU. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check HOLUU's competition here
Silver Spike Acquisition Corp. (NASDAQ: SSPK)
CMLFU vs SSPK Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, SSPK has a market cap of 3.4B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while SSPK trades at $18.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas SSPK's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to SSPK's ROE of +0.04%. Regarding short-term risk, CMLFU is less volatile compared to SSPK. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check SSPK's competition here
Falcon Capital Acquisition Corp. (NASDAQ: FCACU)
CMLFU vs FCACU Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, FCACU has a market cap of 3.4B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while FCACU trades at $9.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas FCACU's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to FCACU's ROE of -0.00%. Regarding short-term risk, CMLFU is less volatile compared to FCACU. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check FCACU's competition here
CF Acquisition Corp. VI (NASDAQ: CFVI)
CMLFU vs CFVI Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, CFVI has a market cap of 3.4B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while CFVI trades at $12.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas CFVI's P/E ratio is -18.55. In terms of profitability, CMLFU's ROE is -0.39%, compared to CFVI's ROE of +0.00%. Regarding short-term risk, CMLFU is less volatile compared to CFVI. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check CFVI's competition here
Holicity Inc. (NASDAQ: HOL)
CMLFU vs HOL Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, HOL has a market cap of 3.3B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while HOL trades at $12.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas HOL's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to HOL's ROE of -0.13%. Regarding short-term risk, CMLFU is less volatile compared to HOL. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check HOL's competition here
Churchill Capital Corp XI Warrants (NASDAQ: CCXIW)
CMLFU vs CCXIW Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, CCXIW has a market cap of 3.2B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while CCXIW trades at $8.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas CCXIW's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to CCXIW's ROE of N/A. Regarding short-term risk, CMLFU is less volatile compared to CCXIW. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check CCXIW's competition here
Tuscan Holdings Corp. (NASDAQ: THCB)
CMLFU vs THCB Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, THCB has a market cap of 3.1B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while THCB trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas THCB's P/E ratio is -81.30. In terms of profitability, CMLFU's ROE is -0.39%, compared to THCB's ROE of -0.23%. Regarding short-term risk, CMLFU is less volatile compared to THCB. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check THCB's competition here
Sustainable Opportunities Acquisition Corp. (NYSE: SOAC)
CMLFU vs SOAC Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, SOAC has a market cap of 2.8B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while SOAC trades at $10.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas SOAC's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to SOAC's ROE of +3.51%. Regarding short-term risk, CMLFU is less volatile compared to SOAC. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check SOAC's competition here
Decarbonization Plus Acquisition Corporation (NASDAQ: DCRBU)
CMLFU vs DCRBU Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, DCRBU has a market cap of 2.8B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while DCRBU trades at $11.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas DCRBU's P/E ratio is -16.00. In terms of profitability, CMLFU's ROE is -0.39%, compared to DCRBU's ROE of -0.84%. Regarding short-term risk, CMLFU is less volatile compared to DCRBU. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check DCRBU's competition here
Ivanhoe Capital Acquisition Corp. (NYSE: IVAN)
CMLFU vs IVAN Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, IVAN has a market cap of 2.7B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while IVAN trades at $7.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas IVAN's P/E ratio is -698.18. In terms of profitability, CMLFU's ROE is -0.39%, compared to IVAN's ROE of -0.32%. Regarding short-term risk, CMLFU is less volatile compared to IVAN. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check IVAN's competition here
Good Works Acquisition Corp. (NASDAQ: GWAC)
CMLFU vs GWAC Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, GWAC has a market cap of 2.6B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while GWAC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas GWAC's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to GWAC's ROE of -0.59%. Regarding short-term risk, CMLFU is less volatile compared to GWAC. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check GWAC's competition here
Landcadia Holdings III, Inc (NASDAQ: LCYAU)
CMLFU vs LCYAU Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, LCYAU has a market cap of 2.6B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while LCYAU trades at $13.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas LCYAU's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to LCYAU's ROE of +0.04%. Regarding short-term risk, CMLFU is more volatile compared to LCYAU. This indicates higher risk in terms of short-term price fluctuations for CMLFU.Check LCYAU's competition here
Fifth Wall Acquisition Corp. I (NASDAQ: FWAA)
CMLFU vs FWAA Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, FWAA has a market cap of 2.4B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while FWAA trades at $12.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas FWAA's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to FWAA's ROE of -0.09%. Regarding short-term risk, CMLFU is less volatile compared to FWAA. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check FWAA's competition here
GS Acquisition Holdings Corp II (NYSE: GSAH)
CMLFU vs GSAH Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, GSAH has a market cap of 2.4B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while GSAH trades at $10.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas GSAH's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to GSAH's ROE of +0.42%. Regarding short-term risk, CMLFU is less volatile compared to GSAH. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check GSAH's competition here
Landcadia Holdings III, Inc (NASDAQ: LCY)
CMLFU vs LCY Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, LCY has a market cap of 2.4B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while LCY trades at $12.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas LCY's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to LCY's ROE of +0.04%. Regarding short-term risk, CMLFU is similarly volatile compared to LCY. This indicates similar risk in terms of short-term price fluctuations for CMLFU.Check LCY's competition here
Foresight Acquisition Corp. (NASDAQ: FORE)
CMLFU vs FORE Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, FORE has a market cap of 2.3B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while FORE trades at $9.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas FORE's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to FORE's ROE of +4.34%. Regarding short-term risk, CMLFU is less volatile compared to FORE. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check FORE's competition here
Revolution Acceleration Acquisition Corp (NASDAQ: RAAC)
CMLFU vs RAAC Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, RAAC has a market cap of 2.2B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while RAAC trades at $9.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas RAAC's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to RAAC's ROE of +0.00%. Regarding short-term risk, CMLFU is less volatile compared to RAAC. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check RAAC's competition here
Supernova Partners Acquisition Company, Inc. (NYSE: SPNV)
CMLFU vs SPNV Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, SPNV has a market cap of 2.2B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while SPNV trades at $8.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas SPNV's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to SPNV's ROE of -0.99%. Regarding short-term risk, CMLFU is less volatile compared to SPNV. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check SPNV's competition here
Social Capital Suvretta Holdings Corp. III (NASDAQ: DNAC)
CMLFU vs DNAC Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, DNAC has a market cap of 2.2B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while DNAC trades at $9.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas DNAC's P/E ratio is -37.72. In terms of profitability, CMLFU's ROE is -0.39%, compared to DNAC's ROE of -0.34%. Regarding short-term risk, CMLFU is less volatile compared to DNAC. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check DNAC's competition here
Fortress Value Acquisition Corp. II (NYSE: FAII)
CMLFU vs FAII Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, FAII has a market cap of 2.1B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while FAII trades at $10.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas FAII's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to FAII's ROE of -0.32%. Regarding short-term risk, CMLFU is less volatile compared to FAII. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check FAII's competition here
dMY Technology Group, Inc. III (NYSE: DMYI)
CMLFU vs DMYI Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, DMYI has a market cap of 2.1B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while DMYI trades at $10.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas DMYI's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to DMYI's ROE of -0.16%. Regarding short-term risk, CMLFU is less volatile compared to DMYI. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check DMYI's competition here
Live Oak Acquisition Corp. II (NYSE: LOKB)
CMLFU vs LOKB Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, LOKB has a market cap of 2.1B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while LOKB trades at $13.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas LOKB's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to LOKB's ROE of -0.62%. Regarding short-term risk, CMLFU is less volatile compared to LOKB. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check LOKB's competition here
Star Peak Corp II (NYSE: STPC)
CMLFU vs STPC Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, STPC has a market cap of 2B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while STPC trades at $9.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas STPC's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to STPC's ROE of -0.29%. Regarding short-term risk, CMLFU is more volatile compared to STPC. This indicates higher risk in terms of short-term price fluctuations for CMLFU.Check STPC's competition here
Mudrick Capital Acquisition Corporation II (NASDAQ: MUDS)
CMLFU vs MUDS Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, MUDS has a market cap of 2B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while MUDS trades at $10.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas MUDS's P/E ratio is 3.39. In terms of profitability, CMLFU's ROE is -0.39%, compared to MUDS's ROE of -0.01%. Regarding short-term risk, CMLFU is more volatile compared to MUDS. This indicates higher risk in terms of short-term price fluctuations for CMLFU.Check MUDS's competition here
Mudrick Capital Acquisition Corporation II (NASDAQ: MUDSU)
CMLFU vs MUDSU Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, MUDSU has a market cap of 2B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while MUDSU trades at $10.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas MUDSU's P/E ratio is -1125.56. In terms of profitability, CMLFU's ROE is -0.39%, compared to MUDSU's ROE of -0.01%. Regarding short-term risk, CMLFU is more volatile compared to MUDSU. This indicates higher risk in terms of short-term price fluctuations for CMLFU.Check MUDSU's competition here
Tiga Acquisition Corp. (NYSE: TINV)
CMLFU vs TINV Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, TINV has a market cap of 2B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while TINV trades at $11.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas TINV's P/E ratio is 30.61. In terms of profitability, CMLFU's ROE is -0.39%, compared to TINV's ROE of +1.23%. Regarding short-term risk, CMLFU is less volatile compared to TINV. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check TINV's competition here
Apex Treasury Corporation Class A (NASDAQ: APXT)
CMLFU vs APXT Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, APXT has a market cap of 1.9B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while APXT trades at $10.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas APXT's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to APXT's ROE of +0.16%. Regarding short-term risk, CMLFU is more volatile compared to APXT. This indicates higher risk in terms of short-term price fluctuations for CMLFU.Check APXT's competition here
Apex Treasury Corporation (NASDAQ: APXTU)
CMLFU vs APXTU Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, APXTU has a market cap of 1.9B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while APXTU trades at $10.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas APXTU's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to APXTU's ROE of +0.16%. Regarding short-term risk, CMLFU is more volatile compared to APXTU. This indicates higher risk in terms of short-term price fluctuations for CMLFU.Check APXTU's competition here
Digital World Acquisition Corp. (NASDAQ: DWAC)
CMLFU vs DWAC Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, DWAC has a market cap of 1.9B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while DWAC trades at $49.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas DWAC's P/E ratio is -73.46. In terms of profitability, CMLFU's ROE is -0.39%, compared to DWAC's ROE of -0.58%. Regarding short-term risk, CMLFU is less volatile compared to DWAC. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check DWAC's competition here
Digital World Acquisition Corp. (NASDAQ: DWACU)
CMLFU vs DWACU Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, DWACU has a market cap of 1.9B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while DWACU trades at $61.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas DWACU's P/E ratio is -451.10. In terms of profitability, CMLFU's ROE is -0.39%, compared to DWACU's ROE of -0.58%. Regarding short-term risk, CMLFU is less volatile compared to DWACU. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check DWACU's competition here
Athena Technology Acquisition Corp. (NYSE: ATHN)
CMLFU vs ATHN Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, ATHN has a market cap of 1.8B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while ATHN trades at $9.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas ATHN's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to ATHN's ROE of +2.24%. Regarding short-term risk, CMLFU is less volatile compared to ATHN. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check ATHN's competition here
Apex Treasury Corporation (NASDAQ: APXTW)
CMLFU vs APXTW Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, APXTW has a market cap of 1.8B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while APXTW trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas APXTW's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to APXTW's ROE of +0.16%. Regarding short-term risk, CMLFU is less volatile compared to APXTW. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check APXTW's competition here
Gores Metropoulos II, Inc. (NASDAQ: GMII)
CMLFU vs GMII Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, GMII has a market cap of 1.8B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while GMII trades at $8.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas GMII's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to GMII's ROE of +0.21%. Regarding short-term risk, CMLFU is less volatile compared to GMII. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check GMII's competition here
Motive Capital Corp. (NYSE: MOTV)
CMLFU vs MOTV Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, MOTV has a market cap of 1.7B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while MOTV trades at $10.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas MOTV's P/E ratio is 55.86. In terms of profitability, CMLFU's ROE is -0.39%, compared to MOTV's ROE of -0.23%. Regarding short-term risk, CMLFU is less volatile compared to MOTV. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check MOTV's competition here
CBRE Acquisition Holdings, Inc. (NYSE: CBAH)
CMLFU vs CBAH Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, CBAH has a market cap of 1.7B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while CBAH trades at $10.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas CBAH's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to CBAH's ROE of +0.04%. Regarding short-term risk, CMLFU is less volatile compared to CBAH. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check CBAH's competition here
GX Acquisition Corp. (NASDAQ: GXGXU)
CMLFU vs GXGXU Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, GXGXU has a market cap of 1.7B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while GXGXU trades at $11.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas GXGXU's P/E ratio is -23.73. In terms of profitability, CMLFU's ROE is -0.39%, compared to GXGXU's ROE of -0.03%. Regarding short-term risk, CMLFU is less volatile compared to GXGXU. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check GXGXU's competition here
One (NYSE: AONE)
CMLFU vs AONE Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, AONE has a market cap of 1.7B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while AONE trades at $8.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas AONE's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to AONE's ROE of -17.11%. Regarding short-term risk, CMLFU is less volatile compared to AONE. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check AONE's competition here
Tortoise Acquisition Corp. II (NYSE: SNPR)
CMLFU vs SNPR Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, SNPR has a market cap of 1.6B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while SNPR trades at $9.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas SNPR's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to SNPR's ROE of +0.00%. Regarding short-term risk, CMLFU is less volatile compared to SNPR. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check SNPR's competition here
Jaws Spitfire Acquisition Corporation (NYSE: SPFR)
CMLFU vs SPFR Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, SPFR has a market cap of 1.6B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while SPFR trades at $8.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas SPFR's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to SPFR's ROE of -4.58%. Regarding short-term risk, CMLFU is less volatile compared to SPFR. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check SPFR's competition here
D8 Holdings Corp. (NYSE: DEH)
CMLFU vs DEH Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, DEH has a market cap of 1.6B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while DEH trades at $11.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas DEH's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to DEH's ROE of -3.33%. Regarding short-term risk, CMLFU is less volatile compared to DEH. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check DEH's competition here
Rotor Acquisition Corp. (NYSE: ROT)
CMLFU vs ROT Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, ROT has a market cap of 1.6B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while ROT trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas ROT's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to ROT's ROE of -0.45%. Regarding short-term risk, CMLFU is less volatile compared to ROT. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check ROT's competition here
NextGen Acquisition Corporation (NASDAQ: NGAC)
CMLFU vs NGAC Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, NGAC has a market cap of 1.5B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while NGAC trades at $8.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas NGAC's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to NGAC's ROE of -0.87%. Regarding short-term risk, CMLFU is less volatile compared to NGAC. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check NGAC's competition here
Celularity Inc. (NASDAQ: GXGX)
CMLFU vs GXGX Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, GXGX has a market cap of 1.5B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while GXGX trades at $10.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas GXGX's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to GXGX's ROE of +4.12%. Regarding short-term risk, CMLFU is less volatile compared to GXGX. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check GXGX's competition here
Hudson Executive Investment Corp. (NASDAQ: HECCU)
CMLFU vs HECCU Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, HECCU has a market cap of 1.4B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while HECCU trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas HECCU's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to HECCU's ROE of -0.10%. Regarding short-term risk, CMLFU is less volatile compared to HECCU. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check HECCU's competition here
Altimar Acquisition Corp. II (NYSE: ATMR)
CMLFU vs ATMR Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, ATMR has a market cap of 1.4B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while ATMR trades at $10.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas ATMR's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to ATMR's ROE of +0.44%. Regarding short-term risk, CMLFU is less volatile compared to ATMR. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check ATMR's competition here
Osprey Technology Acquisition Corp. (NYSE: SFTW)
CMLFU vs SFTW Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, SFTW has a market cap of 1.4B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while SFTW trades at $11.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas SFTW's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to SFTW's ROE of -0.56%. Regarding short-term risk, CMLFU is less volatile compared to SFTW. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check SFTW's competition here
890 5th Avenue Partners, Inc. (NASDAQ: ENFA)
CMLFU vs ENFA Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, ENFA has a market cap of 1.3B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while ENFA trades at $9.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas ENFA's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to ENFA's ROE of -1.15%. Regarding short-term risk, CMLFU is less volatile compared to ENFA. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check ENFA's competition here
Environmental Impact Acquisition Corp. (NASDAQ: ENVI)
CMLFU vs ENVI Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, ENVI has a market cap of 1.3B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while ENVI trades at $8.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas ENVI's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to ENVI's ROE of +0.00%. Regarding short-term risk, CMLFU is less volatile compared to ENVI. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check ENVI's competition here
ArcLight Clean Transition Corp. II (NASDAQ: ACTD)
CMLFU vs ACTD Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, ACTD has a market cap of 1.3B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while ACTD trades at $7.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas ACTD's P/E ratio is -25.50. In terms of profitability, CMLFU's ROE is -0.39%, compared to ACTD's ROE of +0.00%. Regarding short-term risk, CMLFU is less volatile compared to ACTD. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check ACTD's competition here
Vickers Vantage Corp. I (NASDAQ: VCKA)
CMLFU vs VCKA Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, VCKA has a market cap of 1.3B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while VCKA trades at $9.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas VCKA's P/E ratio is 100.11. In terms of profitability, CMLFU's ROE is -0.39%, compared to VCKA's ROE of +1.68%. Regarding short-term risk, CMLFU is less volatile compared to VCKA. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check VCKA's competition here
Thimble Point Acquisition Corp. (NASDAQ: THMA)
CMLFU vs THMA Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, THMA has a market cap of 1.3B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while THMA trades at $9.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas THMA's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to THMA's ROE of +0.00%. Regarding short-term risk, CMLFU is more volatile compared to THMA. This indicates higher risk in terms of short-term price fluctuations for CMLFU.Check THMA's competition here
L&F Acquisition Corp. (NYSE: LNFA)
CMLFU vs LNFA Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, LNFA has a market cap of 1.3B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while LNFA trades at $10.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas LNFA's P/E ratio is 21.06. In terms of profitability, CMLFU's ROE is -0.39%, compared to LNFA's ROE of +0.09%. Regarding short-term risk, CMLFU is less volatile compared to LNFA. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check LNFA's competition here
Fintech Acquisition Corp. IV (NASDAQ: FTIVU)
CMLFU vs FTIVU Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, FTIVU has a market cap of 1.3B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while FTIVU trades at $14.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas FTIVU's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to FTIVU's ROE of -0.14%. Regarding short-term risk, CMLFU is less volatile compared to FTIVU. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check FTIVU's competition here
ACON S2 Acquisition Corp. (NASDAQ: STWO)
CMLFU vs STWO Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, STWO has a market cap of 1.3B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while STWO trades at $8.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas STWO's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to STWO's ROE of +0.00%. Regarding short-term risk, CMLFU is less volatile compared to STWO. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check STWO's competition here
Haymaker Acquisition Corp. III (NASDAQ: HYACU)
CMLFU vs HYACU Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, HYACU has a market cap of 1.2B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while HYACU trades at $10.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas HYACU's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to HYACU's ROE of -0.11%. Regarding short-term risk, CMLFU is more volatile compared to HYACU. This indicates higher risk in terms of short-term price fluctuations for CMLFU.Check HYACU's competition here
Fintech Acquisition Corp. IV (NASDAQ: FTIV)
CMLFU vs FTIV Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, FTIV has a market cap of 1.2B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while FTIV trades at $13.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas FTIV's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to FTIV's ROE of -0.14%. Regarding short-term risk, CMLFU is less volatile compared to FTIV. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check FTIV's competition here
Alpha Healthcare Acquisition Corp. (NASDAQ: AHAC)
CMLFU vs AHAC Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, AHAC has a market cap of 1.1B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while AHAC trades at $10.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas AHAC's P/E ratio is -72.11. In terms of profitability, CMLFU's ROE is -0.39%, compared to AHAC's ROE of -16.18%. Regarding short-term risk, CMLFU is less volatile compared to AHAC. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check AHAC's competition here
Amplitude Healthcare Acquisition Corporation (NASDAQ: AMHC)
CMLFU vs AMHC Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, AMHC has a market cap of 1.1B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while AMHC trades at $10.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas AMHC's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to AMHC's ROE of +0.00%. Regarding short-term risk, CMLFU is less volatile compared to AMHC. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check AMHC's competition here
FTAC Hera Acquisition Corp. (NASDAQ: HERA)
CMLFU vs HERA Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, HERA has a market cap of 1.1B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while HERA trades at $10.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas HERA's P/E ratio is 46.32. In terms of profitability, CMLFU's ROE is -0.39%, compared to HERA's ROE of +0.01%. Regarding short-term risk, CMLFU is more volatile compared to HERA. This indicates higher risk in terms of short-term price fluctuations for CMLFU.Check HERA's competition here
FTAC Hera Acquisition Corp. (NASDAQ: HERAW)
CMLFU vs HERAW Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, HERAW has a market cap of 1.1B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while HERAW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas HERAW's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to HERAW's ROE of +0.01%. Regarding short-term risk, CMLFU is less volatile compared to HERAW. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check HERAW's competition here
FG New America Acquisition Corp. (NYSE: FGNA)
CMLFU vs FGNA Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, FGNA has a market cap of 1.1B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while FGNA trades at $9.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas FGNA's P/E ratio is -4.35. In terms of profitability, CMLFU's ROE is -0.39%, compared to FGNA's ROE of +0.71%. Regarding short-term risk, CMLFU is less volatile compared to FGNA. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check FGNA's competition here
Social Capital Suvretta Holdings Corp. I (NASDAQ: DNAA)
CMLFU vs DNAA Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, DNAA has a market cap of 1.1B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while DNAA trades at $14.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas DNAA's P/E ratio is -54.53. In terms of profitability, CMLFU's ROE is -0.39%, compared to DNAA's ROE of +0.00%. Regarding short-term risk, CMLFU is less volatile compared to DNAA. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check DNAA's competition here
Therapeutics Acquisition Corp. (NASDAQ: RACA)
CMLFU vs RACA Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, RACA has a market cap of 1.1B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while RACA trades at $10.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas RACA's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to RACA's ROE of +0.00%. Regarding short-term risk, CMLFU is less volatile compared to RACA. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check RACA's competition here
Trebia Acquisition Corp. (NYSE: TREB)
CMLFU vs TREB Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, TREB has a market cap of 1.1B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while TREB trades at $9.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas TREB's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to TREB's ROE of -12.26%. Regarding short-term risk, CMLFU is less volatile compared to TREB. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check TREB's competition here
TPG Pace Tech Opportunities Corp. (NYSE: PACE)
CMLFU vs PACE Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, PACE has a market cap of 1.1B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while PACE trades at $11.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas PACE's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to PACE's ROE of -1.52%. Regarding short-term risk, CMLFU is less volatile compared to PACE. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check PACE's competition here
FTAC Hera Acquisition Corp. (NASDAQ: HERAU)
CMLFU vs HERAU Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, HERAU has a market cap of 1.1B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while HERAU trades at $10.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas HERAU's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to HERAU's ROE of +0.01%. Regarding short-term risk, CMLFU is more volatile compared to HERAU. This indicates higher risk in terms of short-term price fluctuations for CMLFU.Check HERAU's competition here
LifeSci Acquisition II Corp. (NASDAQ: LSAQ)
CMLFU vs LSAQ Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, LSAQ has a market cap of 1.1B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while LSAQ trades at $9.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas LSAQ's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to LSAQ's ROE of N/A. Regarding short-term risk, CMLFU is less volatile compared to LSAQ. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check LSAQ's competition here
Stable Road Acquisition Corp. (NASDAQ: SRAC)
CMLFU vs SRAC Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, SRAC has a market cap of 1B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while SRAC trades at $10.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas SRAC's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to SRAC's ROE of -4.03%. Regarding short-term risk, CMLFU is less volatile compared to SRAC. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check SRAC's competition here
FTAC Parnassus Acquisition Corp. (NASDAQ: FTPAW)
CMLFU vs FTPAW Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, FTPAW has a market cap of 1B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while FTPAW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas FTPAW's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to FTPAW's ROE of -0.00%. Regarding short-term risk, CMLFU is more volatile compared to FTPAW. This indicates higher risk in terms of short-term price fluctuations for CMLFU.Check FTPAW's competition here
Sandbridge Acquisition Corporation (NYSE: SBG)
CMLFU vs SBG Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, SBG has a market cap of 1B. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while SBG trades at $8.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas SBG's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to SBG's ROE of -3.15%. Regarding short-term risk, CMLFU is less volatile compared to SBG. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check SBG's competition here
Churchill Capital Corp VII (NYSE: CVII-WT)
CMLFU vs CVII-WT Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, CVII-WT has a market cap of 977.9M. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while CVII-WT trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas CVII-WT's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to CVII-WT's ROE of +0.02%. Regarding short-term risk, CMLFU is more volatile compared to CVII-WT. This indicates higher risk in terms of short-term price fluctuations for CMLFU.Check CVII-WT's competition here
Bleichroeder Acquisition Corp. II (NASDAQ: BBCQW)
CMLFU vs BBCQW Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, BBCQW has a market cap of 977.6M. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while BBCQW trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas BBCQW's P/E ratio is N/A. In terms of profitability, CMLFU's ROE is -0.39%, compared to BBCQW's ROE of N/A. Regarding short-term risk, CMLFU is more volatile compared to BBCQW. This indicates higher risk in terms of short-term price fluctuations for CMLFU.Check BBCQW's competition here
Churchill Capital Corp VII (NYSE: CVII-UN)
CMLFU vs CVII-UN Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, CVII-UN has a market cap of 958.8M. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while CVII-UN trades at $10.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas CVII-UN's P/E ratio is 64.65. In terms of profitability, CMLFU's ROE is -0.39%, compared to CVII-UN's ROE of +0.02%. Regarding short-term risk, CMLFU is less volatile compared to CVII-UN. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check CVII-UN's competition here
B. Riley Principal 150 Merger Corp. (NASDAQ: BRPM)
CMLFU vs BRPM Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, BRPM has a market cap of 944M. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while BRPM trades at $13.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas BRPM's P/E ratio is -72.74. In terms of profitability, CMLFU's ROE is -0.39%, compared to BRPM's ROE of +4.56%. Regarding short-term risk, CMLFU is less volatile compared to BRPM. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check BRPM's competition here
Crescent Acquisition Corp. (NASDAQ: CRSAU)
CMLFU vs CRSAU Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, CRSAU has a market cap of 937.8M. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while CRSAU trades at $10.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas CRSAU's P/E ratio is -27.21. In terms of profitability, CMLFU's ROE is -0.39%, compared to CRSAU's ROE of -0.34%. Regarding short-term risk, CMLFU is less volatile compared to CRSAU. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check CRSAU's competition here
Churchill Capital Corp VII (NYSE: CVII)
CMLFU vs CVII Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, CVII has a market cap of 914.7M. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while CVII trades at $9.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas CVII's P/E ratio is 999.00. In terms of profitability, CMLFU's ROE is -0.39%, compared to CVII's ROE of +0.02%. Regarding short-term risk, CMLFU is more volatile compared to CVII. This indicates higher risk in terms of short-term price fluctuations for CMLFU.Check CVII's competition here
BCTG Acquisition Corp. (NASDAQ: BCTG)
CMLFU vs BCTG Comparison August 2026
CM Life Sciences, Inc. (NASDAQ: CMLFU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLFU stands at 10.3B. In comparison, BCTG has a market cap of 899.4M. Regarding current trading prices, CMLFU is priced at $13.00 on the NASDAQ, while BCTG trades at $10.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLFU currently has a P/E ratio of -1444.44, whereas BCTG's P/E ratio is -204.00. In terms of profitability, CMLFU's ROE is -0.39%, compared to BCTG's ROE of -0.42%. Regarding short-term risk, CMLFU is less volatile compared to BCTG. This indicates lower risk in terms of short-term price fluctuations for CMLFU.Check BCTG's competition here